Elo Mutual Pension Insurance Co increased its stake in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 3.7% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 182,392 shares of the biopharmaceutical company’s stock after acquiring an additional 6,559 […]
Westwood Holdings Group Inc. lifted its stake in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 16.7% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 366,246 shares of the biopharmaceutical company’s stock after buying an additional 52,337 shares during the period. Westwood […]
Homestead Advisers Corp boosted its stake in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 0.2% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 942,589 shares of the biopharmaceutical company’s stock after acquiring an additional 1,600 shares during the quarter. Homestead Advisers Corp’s […]
Cibc World Markets Corp lifted its stake in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 4.7% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 871,423 shares of the biopharmaceutical company’s stock after acquiring an additional 39,117 shares during the period. Cibc World Markets Corp’s holdings […]
Epoch Investment Partners Inc. boosted its stake in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 10.3% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,030,177 shares of the biopharmaceutical company’s stock after buying an additional 96,193 shares […]